Literature DB >> 3082831

Evaluation of response rates to various antitumor agents of human gastric tumors implanted in nude mouse.

M Inaba, T Tashiro, T Kobayashi, S Fujimoto, Y Sakurai, K Maruo, Y Ohnishi, Y Ueyama, T Nomura.   

Abstract

To ascertain the clinical predictability and, in the long run, the usefulness of the human tumor/nude mouse model as a screening tool for antitumor agents, it seems particularly important to use as many tumor lines as possible and to evaluate the therapeutic effectiveness of antitumor agents in terms of the overall response rate of a range of tumors. In this study, using 11 strains of established human gastric tumor xenografts with various histological characteristics and proliferation behavior, the experimental response rates to 8 typical antitumor drugs (mitomycin C, cyclophosphamide, ACNU, cisplatin, adriamycin, vincristine, vinblastine and 5-fluorouracil) were determined and compared with the clinical values. The experimental response rates to adriamycin, vincristine and 5-fluorouracil were in good accordance with the clinical results. However, with the other drugs, significantly higher response rates were observed with the nude mouse model as compared to clinical therapy, indicating that this model tends to overestimate the responsiveness of human tumor to a number of antitumor agents. These results strongly suggest the importance of using appropriate dose levels in the nude mouse to reproduce clinically equivalent effects in this model.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082831

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma.

Authors:  D H Liu; X Y Zhang; D M Fan; Y X Huang; J S Zhang; W Q Huang; Y Q Zhang; Q S Huang; W Y Ma; Y B Chai; M Jin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

3.  Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in beagle dogs.

Authors:  T Noda; T Watanabe; A Kohda; S Hosokawa; T Suzuki
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

4.  Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine).

Authors:  T Narita; Y Koide; S Yaguchi; S Kimura; Y Izumisawa; M Takase; M Inaba; S Tsukagoshi
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Expression of P-glycoprotein mRNA in human gastric tumors.

Authors:  Y Sugimoto; N Asami; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1989-10

6.  Antitumor activity of ME2303, a fluorine-containing anthracycline, against human tumors implanted in nude mice.

Authors:  T Tsuruo; S Sato; K Yusa
Journal:  Jpn J Cancer Res       Date:  1989-07

Review 7.  How translational modeling in oncology needs to get the mechanism just right.

Authors:  James W T Yates; David A Fairman
Journal:  Clin Transl Sci       Date:  2021-11-12       Impact factor: 4.689

8.  Pharmacokinetic approach to rational therapeutic doses for human tumor-bearing nude mice.

Authors:  M Inaba; T Kobayashi; T Tashiro; Y Sakurai
Journal:  Jpn J Cancer Res       Date:  1988-04

9.  Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents.

Authors:  M Inaba; T Tashiro; T Kobayashi; Y Sakurai; K Maruo; Y Ohnishi; Y Ueyama; T Nomura
Journal:  Jpn J Cancer Res       Date:  1988-04

10.  Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts.

Authors:  S Morisada; Y Yanagi; T Noguchi; Y Kashiwazaki; M Fukui
Journal:  Jpn J Cancer Res       Date:  1989-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.